Matrix Metalloproteinases (MMPs) in patients with pulmonary tuberculosis (PT) and comorbid COPD Source: International Congress 2018 – Tuberculosis comorbidities Year: 2018
Total respiratory impedance by impulse oscillometry (IO) in patients with pulmonary tuberculosis (PT) Source: International Congress 2016 – Respiratory muscles and airways function: from physiology to clinical implications Year: 2016
Matrix metalloproteinases (MMPs) and acute phase proteins (APP) in predicting the efficacy of intensive phase treatment (IPP) in patients with pulmonary tuberculosis (PT) Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016
Impulse oscillometry (IO) parameters after pneumonectomy in patients with pulmonary tuberculosis (PT) Source: International Congress 2017 – Lung function testing Year: 2017
Impulse oscillometry (IOS) in emphysema: relationship to conventional lung function indices Source: Eur Respir J 2003; 22: Suppl. 45, 100s Year: 2003
System of matrix metalloproteinases in infiltrative pulmonary tuberculosis (with and without lung tissue destruction) Source: International Congress 2015 – Biomarkers in TB: immunology and physiology Year: 2015
Matrix metalloproteinases (MMPs) and angiogenesis in lung tissue remodeling in different variants of idiopathic interstitial pneumonia (IIP) Source: Eur Respir J 2007; 30: Suppl. 51, 137s Year: 2007
Matrix metalloproteinases (MMPs), tissue inhibitor of matrix metalloproteinases (TIMPs) and transforming growth factor-β (TGFβ) expression in small airways (SA) of usual idiopathic pneumonia (UIP), non-specific interstitial pneumonia (NSIP), hip Source: Annual Congress 2007 - Role of genomics and biological tools in the work-up of interstitial lung disease Year: 2007
Correlation between matrix metalloproteinase-9 serum levels and disease severity in pulmonary tuberculosis patients Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016
Matrix metalloproteinase- 9 (MMP-9) and tissue inhibitor of metalloproteinase-1(TIMP-1) as non-invasive biomarkers of remodelling in asthma Source: International Congress 2015 – Phenotyping asthma with biomarkers Year: 2015
Relationship the impulse oscillometry parameters and the lung damage in idiopathic pulmonary fibrosis patients Source: Annual Congress 2013 –Airway calibre, airway challenge and assessment of oxygenation Year: 2013
Prognostic role of matrix metalloproteinase system / inhibitors in assessing the nature of reparative changes in infiltrative pulmonary tuberculosis (ITL). Source: International Congress 2018 – Triggers of acute lung injury: mechanical ventilation and oxygen levels Year: 2018
The use of impulse oscillometry (IOS) in the differentiation of bronchiectasis and emphysema in patients with alpha1 antitrypsin deficiency (α1 -ATD) Source: Annual Congress 2004 - Airway resistance: application and technique Year: 2004
Pulmonary resistance measured by impulse oscillometry system (IOS) seems to be related to self-reported COPD and respiratory symptoms Source: Annual Congress 2011 - Respiratory epidemiology: methods, definitions and phenotypes Year: 2011
Matrix metalloproteinase (MMP) 9 is associated with clinical parameters of severity in cystic fibrosis (CF) Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010
Matrix metalloproteinase (MMP) 12 is not associated with clinical parameters of severity in cystic fibrosis (CF) Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010
Effect of recombinant α-1 antitrypsin (rAAT) and TAPI on neutrophil elastase (NE) and matrix metalloproteinase-9 (MMP9) activity in induced sputum (IS) from healthy smokers and patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2003 - Progress on therapy for chronic obstructive pulmonary disease Year: 2003
Correlation of serum Matrix metalloproteinase-9 and clinico-functional parameters in COPD patients Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020
Matrix metalloproteinase (MMP) 12 is associated with clinical parameters of disease severity and exacerbations in asthma Source: Annual Congress 2010 - Asthma: basic science and clinical studies Year: 2010
Matrix metalloproteinases in tuberculosis Source: Eur Respir J 2011; 38: 456-464 Year: 2011